CRCM
VRTX icon

Corbett Road Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Corbett Road Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$749K Buy
2,660
+1,332
+100% +$357K 1.28% 24
2022
Q1 		$347K Buy
+1,328
New +$315K 0.45% 81
2020
Q4 		– Sell
-2,266
Closed -$617K – 130
2020
Q3 		$617K Buy
2,266
+81
+4% +$22.3K 0.59% 42
2020
Q2 		$634K Buy
2,185
+805
+58% +$218K 0.61% 35
2020
Q1 		$328K Buy
1,380
+311
+29% +$71.3K 0.47% 37
2019
Q4 		$234K Buy
+1,069
New +$216K 0.23% 100

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Corbett Road Capital Management's VRTX Position: Q2 2022 in Review

Corbett Road Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 100% in Q2 2022, buying an estimated $357K and bringing the position to 2,660 shares worth $749K. The position accounts for 1.28% of the portfolio, ranked #24.

Corbett Road Capital Management first reported a position in VRTX in Q4 2019 and has held it in 6 quarters since. 1,106 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.

  • Corbett Road Capital Management held 2,660 shares of Vertex Pharmaceuticals worth $749K as of Q2 2022.
  • Corbett Road Capital Management bought 1,332 Vertex Pharmaceuticals shares in Q2 2022, an estimated $357K.
  • Vertex Pharmaceuticals made up 1.28% of Corbett Road Capital Management's portfolio in Q2 2022, its #24 holding.
  • Corbett Road Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
  • 1,106 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.

Based on Corbett Road Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.